PF-2545920 hydrochloride
CAS No. ——
PF-2545920 hydrochloride( Mardepodect hydrochloride | MP-10 hydrochloride | PF-02545920 hydrochloride )
Catalog No. M16961 CAS No. ——
A potent and selective PDE10A inhibitor with IC50 of 0.37 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePF-2545920 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective PDE10A inhibitor with IC50 of 0.37 nM.
-
DescriptionA potent and selective PDE10A inhibitor with IC50 of 0.37 nM; displays >1,000-fold selectivity over the PDEs; antagonizes apomorphine-induced climbing in mice, inhibits conditioned avoidance responding in both rats and mice, and blocks NMDA antagonist-induced deficits in prepulse inhibition of acoustic startle response in rats; dose-dependently increases c-Fos immunopositive nuclei in all regions of neostriatum in the DRd1a-tdTomato mice; improves cortico-basal ganglia function in huntington's disease models; orally bioavailable.Schizophrenia Phase 2 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsMardepodect hydrochloride | MP-10 hydrochloride | PF-02545920 hydrochloride
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight428.9135
-
Molecular FormulaC25H21ClN4O
-
Purity>98% (HPLC)
-
SolubilityDMSO
-
SMILES——
-
Chemical NameQuinoline, 2-[[4-[1-methyl-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]methyl]-,hydrochloride(1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Verhoest PR, et al. J Med Chem. 2009 Aug 27;52(16):5188-96.
2. Grauer SM, et al. J Pharmacol Exp Ther. 2009 Nov;331(2):574-90.
3. Beaumont V, et al. Neuron. 2016 Dec 21;92(6):1220-1237.
molnova catalog
related products
-
Ensifentrine
Ensifentrine is a PDE3/4 inhibitor, although its affinity for PDE3(IC50: 0.4 nM) is 3,440 times higher than that for PDE4(IC50: 1479 nM), that is under clinical development for the treatment of asthma and COPD and, potentially, cystic fibrosis.
-
Robustine
Robustine is a natural product, exhibits inhibitory potency against human phosphodiesterase 5 (hPDE5A) in vitro.
-
Sildenafil
Sildenfail is a vasoactive agent used to treat erectile dysfunction and reduce symptoms in patients with pulmonary arterial hypertension (PAH).
Cart
sales@molnova.com